The Oncology Institute, Inc. TOI Oral drug inventory — Total Assets
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s oral drug inventory — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s oral drug inventory — total assets?
- The Oncology Institute, Inc. (TOI) reported oral drug inventory — total assets of $10.75M in Q1 2026.
- How has The Oncology Institute, Inc.'s oral drug inventory — total assets changed year-over-year?
- The Oncology Institute, Inc.'s oral drug inventory — total assets increased by 85.6% year-over-year, from $5.79M to $10.75M.
- What does oral drug inventory — total assets mean?
- This metric represents the ratio of oral oncology drug inventory held by the dispensary segment relative to the company's total asset base. It measures the capital intensity and liquidity commitment tied up in specialized pharmaceutical stock required to support outpatient treatment services. A higher ratio may indicate significant investment in on-site pharmacy capabilities, while also highlighting potential inventory management risks or working capital requirements.